X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Cadila Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs CADILA HEALTHCARE - Comparison Results

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE CADILA HEALTHCARE TTK HEALTHCARE/
CADILA HEALTHCARE
 
P/E (TTM) x 17.8 16.4 108.6% View Chart
P/BV x 4.6 3.7 124.0% View Chart
Dividend Yield % 0.6 1.1 57.2%  

Financials

 TTK HEALTHCARE   CADILA HEALTHCARE
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
CADILA HEALTHCARE
Mar-18
TTK HEALTHCARE/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs663558 118.9%   
Low Rs399362 110.4%   
Sales per share (Unadj.) Rs535.6116.3 460.6%  
Earnings per share (Unadj.) Rs15.917.9 89.2%  
Cash flow per share (Unadj.) Rs20.023.1 86.6%  
Dividends per share (Unadj.) Rs4.003.50 114.3%  
Dividend yield (eoy) %0.80.8 98.9%  
Book value per share (Unadj.) Rs137.685.4 161.1%  
Shares outstanding (eoy) m7.771,023.74 0.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.04.0 25.1%   
Avg P/E ratio x33.325.7 129.5%  
P/CF ratio (eoy) x26.519.9 133.5%  
Price / Book Value ratio x3.95.4 71.7%  
Dividend payout %25.119.6 128.1%   
Avg Mkt Cap Rs m4,127470,664 0.9%   
No. of employees `0001.711.8 14.5%   
Total wages/salary Rs m60718,545 3.3%   
Avg. sales/employee Rs Th2,436.710,072.7 24.2%   
Avg. wages/employee Rs Th355.21,569.1 22.6%   
Avg. net profit/employee Rs Th72.51,547.7 4.7%   
INCOME DATA
Net Sales Rs m4,162119,049 3.5%  
Other income Rs m611,132 5.4%   
Total revenues Rs m4,223120,181 3.5%   
Gross profit Rs m19728,475 0.7%  
Depreciation Rs m325,388 0.6%   
Interest Rs m30911 3.3%   
Profit before tax Rs m19723,308 0.8%   
Minority Interest Rs m0628 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m735,644 1.3%   
Profit after tax Rs m12418,292 0.7%  
Gross profit margin %4.723.9 19.8%  
Effective tax rate %37.024.2 152.8%   
Net profit margin %3.015.4 19.4%  
BALANCE SHEET DATA
Current assets Rs m1,62982,005 2.0%   
Current liabilities Rs m1,05860,720 1.7%   
Net working cap to sales %13.717.9 76.7%  
Current ratio x1.51.4 114.0%  
Inventory Days Days3073 40.7%  
Debtors Days Days3498 34.2%  
Net fixed assets Rs m55683,703 0.7%   
Share capital Rs m781,024 7.6%   
"Free" reserves Rs m87886,421 1.0%   
Net worth Rs m1,06987,445 1.2%   
Long term debt Rs m15925,551 0.6%   
Total assets Rs m2,399180,653 1.3%  
Interest coverage x7.626.6 28.5%   
Debt to equity ratio x0.10.3 50.8%  
Sales to assets ratio x1.70.7 263.2%   
Return on assets %6.410.6 60.3%  
Return on equity %11.620.9 55.4%  
Return on capital %18.522.0 83.9%  
Exports to sales %0.80-   
Imports to sales %1.40-   
Exports (fob) Rs m33NA-   
Imports (cif) Rs m58NA-   
Fx inflow Rs m3342,683 0.1%   
Fx outflow Rs m6311,242 0.6%   
Net fx Rs m-3031,441 -0.1%   
CASH FLOW
From Operations Rs m1279,193 1.4%  
From Investments Rs m-146-9,737 1.5%  
From Financial Activity Rs m22515 4.3%  
Net Cashflow Rs m3-29 -8.6%  

Share Holding

Indian Promoters % 65.4 74.8 87.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 8.3 44.6%  
FIIs % 5.2 5.9 88.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 11.0 234.5%  
Shareholders   12,723 44,069 28.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   ALEMBIC LTD  SUN PHARMA  PIRAMAL ENTERPRISES  GLENMARK PHARMA  AUROBINDO PHARMA  

Compare TTK HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 404 Points Higher; Metal and Oil & Gas Stocks Witness Buying(Closing)

Indian share markets continued their momentum during closing hours and ended the day on a strong note. Gains were largely seen in the metal sector and oil & gas sector.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 60.1% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, TTK HEALTHCARE has posted a net profit of Rs 49 m (down 60.1% YoY). Sales on the other hand came in at Rs 1 bn (up 2.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 15.3% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, TTK HEALTHCARE has posted a net profit of Rs 67 m (down 15.3% YoY). Sales on the other hand came in at Rs 2 bn (up 16.3% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 18.6% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (down 18.6% YoY). Sales on the other hand came in at Rs 30 bn (down 8.4% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of CADILA HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

More Views on News

Most Popular

The RCom Bankruptcy: 5 Lessons for Smallcap Investors(Profit Hunter)

Feb 7, 2019

Managements of companies can create or ruin their fortunes. Why is management quality such an important factor in valuing businesses? Read on to find out...

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

How We Pick the Most Profitable Stocks from the Portfolios of Super Investors(The 5 Minute Wrapup)

Feb 8, 2019

This is the trick to following super investors and not losing money.

Don't Be Afraid of the Market; Buy Stocks Like This One(The 5 Minute Wrapup)

Feb 14, 2019

During this tough period in the market, a contrarian approach holds huge potential upside for this Smart Money Secrets stock.

Small Caps Under Seige: Could This Be A Once-in-a-Decade Wealth Creating Opportunity?(Profit Hunter)

Feb 14, 2019

Don't let the dark clouds hovering over small caps scare you into hiding; it will rain gold as sentiments recover. Indeed, there is a blood bath. And if you are a first time investor, the correction is deep enough to scare you out of markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Feb 20, 2019 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 5-YR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS